ATLASKaryopharm Therapeutics (KPTI) earnings date: expected January 15–21
Karyopharm Therapeutics (KPTI) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around January 15–21. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on KPTI
| Last price | $0.11 (-83.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Karyopharm Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 15–21 (estimate). One email the day before, with ATLAS’s read on Karyopharm Therapeutics. You can switch it off at any time.
Alert me before KPTI reportsFree to start. Creating an account takes under a minute.
Notify me when Karyopharm Therapeutics reports
Track KPTI free Add Karyopharm Therapeutics to a free ATLAS watchlist and see its next report date in one place.
KPTI earnings at a glance
| Next report | Not announced · expected around January 15–21 (ATLAS estimate) |
|---|---|
| Last report | Nov 2, 2026 |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -18.3% |
| Average move around a report | ±6.3% (last 4) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Karyopharm Therapeutics’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Karyopharm Therapeutics earnings history: last 5 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 2, 2026 | -$1.15 | – | – | – | – |
| Aug 13, 2026 | -$1.39 | -$2.32 | -66.9% | Miss | -0.5% |
| Jul 23, 2026 | $3.32 | $3.52 | +6.0% | Beat | +3.2% |
| Jun 2, 2026 | $0.23 | $0.17 | -26.1% | Miss | -8.4% |
| May 14, 2026 | -$1.44 | -$1.24 | +13.9% | Beat | -13.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for KPTI
See the fair value, the probability range and the earnings history of Karyopharm Therapeutics on its ATLAS page.
Karyopharm Therapeutics (KPTI) stock analysisPlans from €3.99 a month.
Karyopharm Therapeutics earnings: frequently asked questions
When is Karyopharm Therapeutics (KPTI) next earnings date?
Karyopharm Therapeutics has not announced its next report. Its last 3 reports came Nov 2, 2026, Aug 13, 2026, Jun 2, 2026, so ATLAS estimates the next one around January 15–21. This is an estimate based on that pattern, not a confirmed date.
How often does KPTI beat earnings estimates?
Of its last 4 reports with a recorded result, Karyopharm Therapeutics beat the EPS estimate 2 times; the average surprise was -18.3%. Past results do not predict the next one.
How much does KPTI move around earnings?
Over its last 4 reports the stock moved an average of 6.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
How much does KPTI usually move in a day?
On a normal trading day the ATLAS model puts KPTI’s one-day range at about ±10.5%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer